360° SearchNetwork Hot Spots Trends Time Series

Advanced Search Options >>

Lovenox

Type: Product

Name: Lovenox

First reported Jun 13 2013 - Updated Jun 13 2013 - 1 reports

Teva Pharmaceutical Industries Ltd

Why the Pfizer-Teva Settlement Affects the Whole Industy

It's a 100% FREE Motley Fool service...Generic-drug makers are always on the hunt for the next branded drug to take down. But they can't just go about launching copycats of every drug; it's against the law to sell a generic version of a drug that's under ... [Published Motley Fool Discussion Boards - Jun 13 2013]

Entities: Patent, Teva Pharmaceutical Industries Ltd, Takeda Pharmaceutical Co Ltd, Generic Version

First reported Jun 06 2013 - Updated Jun 06 2013 - 2 reports

Momenta Pharmaceuticals Inc

Momenta Pharma rises following upgrade from UBS

NEW YORK -- Shares of Momenta Pharmaceuticals Inc. jumped Thursday after a UBS analyst upgraded the shares, saying she thinks it's more likely the company will be able to start selling a generic version of the multiple sclerosis drug Copaxone in the next ... [Published CNBC - Jun 06 2013]

Entities: Momenta Pharmaceuticals Inc, Copaxone, UBS AG, Lovenox, Stocks

First reported Jun 05 2013 - Updated Jun 05 2013 - 1 reports

Momenta Spars with Amphastar; Says Federal Circuit’s LOVENOX Safe Harbor Decision Must be Taken Up by the Supreme Court

By Kurt R. Karst –Earlier this week, Momenta Pharmaceuticals, Inc. and Sandoz Inc. (“Petitioners”) filed their reply to the brief filed late last month by Amphastar Pharmaceuticals, Inc. (“Amphastar”) opposing Petitioners’ petition the U.S. Supreme Court ... [Published FDA Law Blog - Jun 05 2013]

Entities: Amphastar Pharmaceuticals Inc, Federal, Lovenox, Supreme Court

First reported Jun 04 2013 - Updated Jun 04 2013 - 1 reports

Are Pharma Sales Made Prior to Patent Invalidation Subject to False Claims Act Suits?

We invite you to join other members of the local biotech and pharmaceutical industry for a breakfast seminar with Fish Principal José Sierra and Senior Principal John Freeman, who will discuss how patent prosecution "misconduct," even if not meeting the ... [Published Fish & Richardson - Jun 04 2013]

Entities: Amphastar Pharmaceuticals Inc, Patent, Lovenox, John Freeman

First reported May 22 2013 - Updated May 23 2013 - 3 reports

Why Momenta Offers A Unique Opportunity In The Pharmaceutical Industry

Home » Blogs » Momenta (MNTA) is a pharmaceutical company that focuses on developing generic or biosimilar versions of extremely complex drugs. The biologic market brings in over $100 billion a year in revenue so even if Momenta can grab a tiny portion ... [Published BioPortfolio - May 23 2013]

Entities: Lovenox, Sandoz, Biotechnology, Molecular Weight, Heparin

First reported May 21 2013 - Updated May 21 2013 - 1 reports

Actavis

Staff and Wire reports

Wal-Mart asked for more info on bribery questionA judge in Delaware ordered attorneys for Wal-Mart Stores Inc. to turn over more information to shareholders seeking records on how the company responded to allegations of bribery involving its operations ... [Published Tulsa World - May 21 2013]

Entities: Actavis, Wal-Mart Stores Inc, Dollar Weaker, Bribery, Warner Chilcott plc

First reported May 02 2013 - Updated May 02 2013 - 1 reports

Sanofi SA

Sanofi's net profit drops by 45% to Euro 1,004 million in Q1

Sanofi has suffered heavy setback during the first quarter ended March 2013 on account of loss of exclusivity of its major product during 2012. Its net sales declined by 5.3 per cent to Euro 8,059 million from Euro 8,511 million in the similar period ... [Published PharmaBiz - May 02 2013]

Entities: Sanofi SA, Declination, Net Profit, Aprovel, Plavix

First reported Apr 25 2013 - Updated Apr 25 2013 - 1 reports

Court Rules in Novel False Claims Act Case Where One Pharmaceutical Company Sues Another

By Delia A. Stubbs – The U.S. District Court for the Eastern District of California issued a ruling last week in an unusual, if not unprecedented, case arising from alleged federal False Claims Act (“FCA”) violations where one drug manufacture has sued ... [Published FDA Law Blog - Apr 25 2013]

Entities: Sanofi SA, Amphastar Pharmaceuticals Inc, Enoxaparin, Lovenox

First reported Mar 28 2013 - Updated Mar 28 2013 - 1 reports

LOVENOX (Enoxaparin Sodium) Injection [Sanofi-Aventis U.S. LLC]

Updated Date: Mar 28, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - Mar 28 2013]

Entities: Enoxaparin sodium, Sanofi-aventis US, Lovenox

First reported Mar 14 2013 - Updated Mar 14 2013 - 1 reports

Momenta Pharmaceuticals Management Presents at Barclays Healthcare Conference - Transcript

Momenta Pharmaceuticals, Inc. ( MNTA ) Barclays Healthcare Conference March 14, 2013 09:00 AM ET Executives Richard Shea - SVP and CFO Analysts Presentation Richard Shea Good morning and welcome. I'm Rick Shea, CFO at Momenta Pharmaceuticals ... [Published Transcripts from Seeking Alpha - Mar 14 2013]

Entities: Momenta Pharmaceuticals Inc, Healthcare Conference, Barclays PLC, Richard Shea

First reported Feb 25 2013 - Updated Feb 25 2013 - 1 reports

U.S. Supreme Court Asked to Review Hatch-Waxman “Safe Harbor” LOVENOX Method Patent Case

By Kurt R. Karst –In a widely anticipated move, Momenta Pharmaceuticals, Inc. and Sandoz Inc. have petitioned the U.S. Supreme Court to review the August 3, 2012 judgment of the U.S. Court of Appeals for the Federal Circuit, in which a divided (2-1) Federal ... [Published FDA Law Blog - Feb 25 2013]

Entities: Patent, Amphastar Pharmaceuticals Inc, Lovenox, Federal, US Supreme Court

First reported Feb 07 2013 - Updated Feb 07 2013 - 1 reports

Sanofi's net plunges by 71% to â¬438 million in Q4

Sanofi, a French pharma major, has suffered heavy setback during the fourth quarter ended December 2012 on account of generic competition, loss of exclusivity in US for several drugs and EU austerity measures. The company's net income declined sharply ... [Published PharmaBiz - Feb 07 2013]

Entities: Sanofi SA, Declination, Aprovel, Eloxatin, Lovenox

Quotes

...the bet, like for Momenta Pharmaceuticals when he shorted the company before the FDA delayed approval of Momenta's generic version of Sanofi "s Lovenox in 2007 and then went long when the drug was finally approved in 2010. The big profits came when most investors weren't expecting approvals. Liang's biggest gain came from approval of Vanda Pharmaceuticals " Fanapt after the surprise approval . No one saw that one coming

White Collar Criminals Love Biotech Stocks [Published EquityJungle - v0.1 - Jun 15 2013]

That cascade "is a series of events by which different compounds are generated and ultimately result in blood coagulation [clotting]."

Comparing the New Blood Thinners to Warfarin [Published Fox 16 - May 31 2013]

More From BioPortfolio on "Why Momenta Offers A Unique Opportunity In The Pharmaceutical Industry"

Why Momenta Offers A Unique Opportunity In The Pharmaceutical Industry [Published BioPortfolio - May 23 2013]

More Content

sort by: Date \| Relevance
White Collar Criminals Love Biotech Stocks [Published EquityJungle - v0.1 - Jun 15 2013]
Why the Pfizer-Teva Settlement Affects the Whol... [Published Motley Fool Discussion Boards - Jun 13 2013]
Sanofi's Fluzone Quadrivalent Gets FDA Nod - An... [Published Zacks.com - Jun 13 2013]
Sanofi's Fluzone Quadrivalent Gets FDA Nod [Published Yahoo! Singapore - Jun 13 2013]
Sanofi's Fluzone Quadrivalent Gets FDA Nod Zacks [Published Yahoo! Finance - Jun 13 2013]
CHMP Positive on Sanofi's Lantus [Published Yahoo! Finance - Jun 11 2013]
Momenta Pharma rises following upgrade from UBS [Published CNBC - Jun 06 2013]
Momenta pleads for Supreme Court review in Love... [Published FiercePharma - Jun 06 2013]
Momenta Spars with Amphastar; Says Federal Circ... [Published FDA Law Blog - Jun 05 2013]
Pipeline Setbacks at Sanofi Zacks [Published Yahoo! Finance - Jun 04 2013]
Are Pharma Sales Made Prior to Patent Invalidat... [Published Fish & Richardson - Jun 04 2013]
Comparing the New Blood Thinners to Warfarin [Published Fox 16 - May 31 2013]
Air Lease Corp (AL), Ford Motor Company (F), Mo... [Published InsiderMonkey.com - May 30 2013]
The 5 Best Dividend Stocks of 2020 [Published Daily Finance - May 26 2013]
Why Momenta Offers A Unique Opportunity In The ... [Published BioPortfolio - May 23 2013]
New Oral Anticoagulants Markets [Published Zecco - May 22 2013]
Momenta Pharmaceuticals Management Presents at ... [Published Seeking Alpha - May 22 2013]
Why Momenta Offers A Unique Opportunity In The ... [Published Seeking Alpha - May 22 2013]
Staff and Wire reports [Published Tulsa World - May 21 2013]
Sanofi's net profit drops by 45% to Euro 1,004 ... [Published PharmaBiz - May 02 2013]
Court Rules in Novel False Claims Act Case Wher... [Published FDA Law Blog - Apr 25 2013]
LOVENOX (Enoxaparin Sodium) Injection [Sanofi-A... [Published DailyMed Drug Label Updates for the last seven ... - Mar 28 2013]
Momenta Pharmaceuticals Management Presents at ... [Published Transcripts from Seeking Alpha - Mar 14 2013]
U.S. Supreme Court Asked to Review Hatch-Waxman... [Published FDA Law Blog - Feb 25 2013]
Drug Costs In Hospitals & Clinics To Rise 4 Per... [Published Pharmalot - Feb 19 2013]
After The Twists And Turns, Sanofi Still A Value [Published Healthcare Sector and Stocks Analysis from Seek ... - Feb 12 2013]
Sanofi's net plunges by 71% to â¬438 million in Q4 [Published PharmaBiz - Feb 07 2013]
Sanofi appoints Dr Paul Chew as CMO, head of Gl... [Published PharmaBiz - Oct 01 2012]

Blogs

sort by: Date \| Relevance
White Collar Criminals Love Biotech Stocks [Published EquityJungle - v0.1 - Jun 15 2013] Filed under: Investing It's understandably very tempting for people with inside information to trade biotech stocks. With the potential for overnight doubles and triples after binary events, there's quick money to be made. They shouldn't. It's illegal. ...
Momenta Spars with Amphastar; Says Federal Circ... [Published FDA Law Blog - Jun 05 2013] By Kurt R. Karst –Earlier this week, Momenta Pharmaceuticals, Inc. and Sandoz Inc. (“Petitioners”) filed their reply to the brief filed late last month by Amphastar Pharmaceuticals, Inc. (“Amphastar”) opposing Petitioners’ petition the U.S. Supreme Court ...
Court Rules in Novel False Claims Act Case Wher... [Published FDA Law Blog - Apr 25 2013] By Delia A. Stubbs – The U.S. District Court for the Eastern District of California issued a ruling last week in an unusual, if not unprecedented, case arising from alleged federal False Claims Act (“FCA”) violations where one drug manufacture has sued ...
LOVENOX (Enoxaparin Sodium) Injection [Sanofi-A... [Published DailyMed Drug Label Updates for the last seven ... - Mar 28 2013] Updated Date: Mar 28, 2013 EST ...
U.S. Supreme Court Asked to Review Hatch-Waxman... [Published FDA Law Blog - Feb 25 2013] By Kurt R. Karst –In a widely anticipated move, Momenta Pharmaceuticals, Inc. and Sandoz Inc. have petitioned the U.S. Supreme Court to review the August 3, 2012 judgment of the U.S. Court of Appeals for the Federal Circuit, in which a divided (2-1) Federal ...